Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperbaric oxygen therapy for acute ischaemic stroke.

M H Bennett1, J Wasiak, A Schnabel

  • 1Diving and Hyperbaric Medicine, Prince of Wales Hospital, Barker Street, Randwick, NSW, Australia, 2031. m.bennett@unsw.edu.au

The Cochrane Database of Systematic Reviews
|July 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis, treatment and monitoring of chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) - Evidence, practice and consensus-based recommendations from the German pediatric rheumatology society (GKJR).

Autoimmunity reviews·2026
Same author

Die Anaesthesiologie·2025
Same author

[The new S2k guidelines on hypertensive diseases during pregnancy (HES): diagnosis and treatment-What do anesthetists need to know?]

Die Anaesthesiologie·2025
Same author

[Risk factors and treatment of post-dural puncture headache-an analysis of the German patients of the international EPIMAP study].

Die Anaesthesiologie·2025
Same author

Endothelial ENaC as a repressor of oxidative stress and a guardian of lung capillary barrier function in bacterial and viral pneumonia.

Frontiers in physiology·2025
Same author

Generating a highly uniform magnetic field inside the magnetically shielded room of the n2EDM experiment.

The European physical journal. C, Particles and fields·2025

Hyperbaric oxygen therapy (HBOT) did not show significant improvements in clinical outcomes for acute ischemic stroke patients. While some disability measures improved, overall evidence suggests limited benefit, warranting further research.

Area of Science:

  • Neurology
  • Hyperbaric Medicine
  • Stroke Research

Background:

  • Ischemic stroke, caused by impaired blood flow to the brain, leads to cell death due to oxygen deprivation.
  • Hyperbaric oxygen therapy (HBOT) is hypothesized to reduce brain damage by increasing oxygen availability and decreasing swelling.
  • Some medical centers currently employ HBOT as a routine treatment for stroke.

Purpose of the Study:

  • To evaluate the efficacy and safety of using HBOT as an additional treatment for acute ischemic stroke.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases including Cochrane Stroke Group Trials Register, CENTRAL, MEDLINE, EMBASE, CINAHL, and DORCTHIM up to July 2004.
  • Randomized controlled trials comparing adjunctive HBOT with no HBOT (control or sham treatment) were included.

Related Experiment Videos

  • Data extraction and validity assessment were performed independently by two authors, with discrepancies resolved through discussion.

    • Main Results:

    • Three randomized controlled trials involving 106 participants met the inclusion criteria, with generally high methodological quality.
    • No significant difference in mortality rates at six months was observed between the HBOT and control groups.
    • While two specific disability and functional scales showed improvement at one year with HBOT, these findings were not consistently replicated across other measures or trials.

    Conclusions:

    • Current evidence from this systematic review does not support the effectiveness of HBOT in improving clinical outcomes for acute ischemic stroke.
    • The limited evidence from three randomized controlled trials suggests that clinical benefit from HBOT is unlikely.
    • Further research is necessary to definitively establish the role of HBOT in managing acute ischemic stroke.